Drugs / FLUDARABINE
FLUDARABINE
also known as
Fludarabina · 2-f-araa · 2-fluoro ara-a · 2-fluorovidarabine · Fluradosa · NSC-118218 · NSC-118218H
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01969942 | Apr 2013 → Oct 2016 | Ewing sarcoma | University of Louisville | Withdrawn | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00774826 | Dec 2005 → Sep 2010 | follicular lymphoma | Fondazione Italiana Linfomi - ETS | Unknown | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUDARABINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1568 ↗ |
| Known as | 2-f-araa | ChEMBL registry synonym — accepted as the source's own label CHEMBL1568 ↗ |
| Known as | 2-fluoro ara-a | ChEMBL registry synonym — accepted as the source's own label CHEMBL1568 ↗ |
| Known as | 2-fluorovidarabine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1568 ↗ |
| Known as | Fludarabina | “Rituximab: 375 mg/mq day 1, Fludarabina: 25 mg/mq day 1-3, Mitoxantrone: 10 mg/mq day 1,” NCT00774826 ↗ |
| Known as | Fluradosa | ChEMBL registry synonym — accepted as the source's own label CHEMBL1568 ↗ |
| Known as | NSC-118218 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1568 ↗ |
| Known as | NSC-118218H | ChEMBL registry synonym — accepted as the source's own label CHEMBL1568 ↗ |
| Modality | Small molecule | — CHEMBL1568 ↗ |